Aralez Pharmaceuticals Inc (ARZ) Insider Sells C$24,900.00 in Stock
Aralez Pharmaceuticals Inc (TSE:ARZ) insider James Patrick Tursi sold 9,960 shares of the business’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of C$2.50, for a total value of C$24,900.00.
Aralez Pharmaceuticals Inc (TSE:ARZ) traded up 9.51% on Wednesday, reaching $3.11. The company had a trading volume of 86,323 shares. The company has a 50-day moving average of $2.20 and a 200 day moving average of $2.20. The stock’s market cap is $207.90 million. Aralez Pharmaceuticals Inc has a one year low of $1.46 and a one year high of $7.35.
WARNING: “Aralez Pharmaceuticals Inc (ARZ) Insider Sells C$24,900.00 in Stock” was posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/10/04/aralez-pharmaceuticals-inc-arz-insider-sells-c24900-00-in-stock.html.
Aralez Pharmaceuticals Company Profile
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Ratings for Aralez Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.